Overview
- 23 inspections across 22 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-10-17.
At a glance
Inspections
23
Sites
22
Observations
0
Career since
Sep 2014
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| GI Accelerate Memphis LLC | 17 Oct 2025 | Biologics | On file |
| BIOMAY AG | 10 Dec 2024 | Biologics | |
| GI Accelerate Memphis LLC | 11 Oct 2024 | Biologics | On file |
| Miltenyi Biotec, Inc | 3 May 2024 | Biologics | On file |
| Abeona Therapeutics Inc. | 1 Mar 2024 | Biologics | On file |
Sites inspected
GI Accelerate Memphis LLCMemphis, United States2 insp.
BIOMAY AGVienna, Austria1 insp.
Miltenyi Biotec, IncGaithersburg, United States1 insp.
Abeona Therapeutics Inc.Cleveland, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Ou Ma3 shared
Alan G Baer2 shared
Zainab Y Mansaray-Storms2 shared
Graeme E Price2 shared
Hector A Carrero2 shared
Andrew P Byrnes2 shared
Wei Wang2 shared
Susan S Yu2 shared
Shaina R Fullwood1 shared
Bao-Ngoc B Nguyen1 shared
Full investigator report
Get the verbatim findings behind Christine Harman's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site